Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Sell
61,978
-82
-0.1% -$1.9K 0.26% 75
2025
Q4
$1.44M Buy
62,060
+2,100
+4% +$50.6K 0.27% 69
2025
Q3
$1.7M Sell
59,960
-535
-0.9% -$14.2K 0.33% 60
2025
Q2
$1.33M Hold
60,495
0.33% 63
2025
Q1
$1.41M Sell
60,495
-23,088
-28% -$590K 0.34% 65
2024
Q4
$2.4M Sell
83,583
-19,629
-19% -$587K 0.56% 50
2024
Q3
$3.06M Buy
103,212
+699
+0.7% +$21.7K 0.7% 50
2024
Q2
$3.46M Hold
102,513
0.86% 39
2024
Q1
$3.7M Sell
102,513
-4,063
-4% -$141K 0.92% 40
2023
Q4
$3.48M Buy
106,576
+237
+0.2% +$7.32K 0.91% 40
2023
Q3
$3.46M Hold
106,339
1.01% 38
2023
Q2
$3.11M Sell
106,339
-395
-0.4% -$10.9K 0.86% 40
2023
Q1
$2.99M Buy
106,734
+88
+0.1% +$2.48K 0.89% 38
2022
Q4
$2.91M Buy
+106,646
New +$2.85M 0.9% 36

Other funds holding GNTX

Legacy Trust's GNTX Position: Q1 2026 in Review

Legacy Trust reduced its Gentex (GNTX) stake by 0.13% in Q1 2026, selling an estimated $1.9K and leaving 61,978 shares worth $1.35M. The position accounts for 0.26% of the portfolio, ranked #75.

Legacy Trust first reported a position in GNTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.7M in Q1 2024. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • Legacy Trust held 61,978 shares of Gentex worth $1.35M as of Q1 2026.
  • Legacy Trust sold 82 Gentex shares in Q1 2026, an estimated $1.9K.
  • Gentex made up 0.26% of Legacy Trust's portfolio in Q1 2026, its #75 holding.
  • Legacy Trust first reported a position in Gentex in Q4 2022 and has held it in 14 quarters since.
  • Legacy Trust's Gentex position peaked at $3.7M in Q1 2024.
  • 501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.